PCNA and cardiofaciocutaneous syndrome: The skin with CFC was defined by the presence of epidermal hyperplasia (hypergranulosis with orthokeratotic acanthosis) together with molecular markers, such as an increase in PCNA immunostaining and PIPs restricted to the lower levels of the epidermis, in the absence of keratinocyte atypia and inflammatory infiltrates.